explore -WSS

explore

author：entertainment 2025-09-30 14:10:10 - browse：8

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： More regulation could be coming for drug ads

knowledge

WSS

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Cue Health's Covid

Key Senate committee drafts bipartisan bill to stem drug shortages

Judge rejects Trump's counterclaim against E. Jean Carroll

Diversity in clinical trials starts with building trust, experts say

Cancer researcher Catriona Jamieson is sending tumors into space

focus

explore

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Dogs on Prozac: What pet anti

Novavax promises a turnaround & Lilly roils the obesity market

Q&A: Jennifer Adair on making gene therapy available globally

Moonlake's readout produced a cash windfall. Risks remain

Former Georgia lieutenant governor says he received grand jury subpoena

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Element Biosciences CEO lays out genome sequencing strategy

New air purifier tech could be key to improving indoor air quality

Medical bills so high, Medicare adding extra digits to claim forms

leisure time

Cue Health's Covid

Wegovy cuts risk of cardiovascular events by 20%, study finds

Ohioans vote in high

Wegovy cuts risk of cardiovascular events by 20%, study finds

Choosing scientific sides in the fight against Alzheimer's

Why does health care cost so much? A reading guide

knowledge

focus

entertainment

hotspot